Cargando…
UBE2T knockdown inhibits gastric cancer progression
Ubiquitin-conjugating enzymes (E2 enzymes) such as UBE2T target proteins for degradation via the proteasome. Here, we examined the effects of UBE2T on the progression of gastric cancer. UBE2T was highly expressed in gastric tumors and gastric cancer cells. siRNA-mediated suppression of UBE2T inhibit...
Autores principales: | Luo, Changjiang, Yao, Yunyi, Yu, Zeyuan, Zhou, Huinian, Guo, Lingyun, Zhang, Junqiang, Cao, Hongtai, Zhang, Genyuan, Li, Yumin, Jiao, Zuoyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464816/ https://www.ncbi.nlm.nih.gov/pubmed/28427240 http://dx.doi.org/10.18632/oncotarget.15947 |
Ejemplares similares
-
Correction: UBE2T knockdown inhibits gastric cancer progression
por: Luo, Changjiang, et al.
Publicado: (2023) -
A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination
por: Yu, Zeyuan, et al.
Publicado: (2020) -
Pancreatic fistula after pancreatoduodenectomy due to compression of the superior mesenteric vessels: a case report
por: Yang, Hanteng, et al.
Publicado: (2020) -
Survival Benefit of Metformin Use for Pancreatic Cancer Patients Who Underwent Pancreatectomy: Results From a Meta-Analysis
por: Zhang, Junqiang, et al.
Publicado: (2020) -
Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma
por: Guo, Lingyun, et al.
Publicado: (2020)